Dow Down 0.17% Nasdaq Down 0.28%

Novavax, Inc. (NVAX)

-NasdaqGS
4.17 Down 0.15(3.47%) 4:00PM EDT
|After Hours : 4.17 Down 0.00 (0.07%) 4:38PM EDT
Prev Close:4.32
Open:4.31
Bid:4.13 x 800
Ask:4.20 x 800
1y Target Est:10.58
Beta:1.04
Earnings Date:Nov 5 - Nov 10 (Est.)
Day's Range:4.16 - 4.35
52wk Range:2.68 - 6.95
Volume:3,906,496
Avg Vol (3m):2,937,710
Market Cap:992.89M
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVAX

Comparison

Symbol% ChgMkt Cap
NVAXDown 3.47%992.89M
MRKDown 0.22%171.00B
NVSUp 0.61%228.38B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):35.14
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.07
Mean Recommendation*:1.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novavax, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing recombinant protein nanoparticle vaccines and adjuvants. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback